Xuemin Xu

3.3k citations
92 papers · 2.7k indexed · h-index 33
Topics
Alzheimer's disease research and treatments (19 papers)Mitochondrial Function and Pathology (11 papers)Protein Kinase Regulation and GTPase Signaling (11 papers)
Partner nations
United StatesChinaJapan

In The Last Decade

Xuemin Xu

88 papers receiving 2.7k citations

Peers

Xuemin Xu
Comparison fields: 5 of 145
  • Molecular Biology 1.6k
  • Physiology 636
  • Immunology 496
  • Cell Biology 360
  • Pharmacology 220
Replace Marcela Briššová with:
Marcela Briššová United States
Roland Stein United States
Bangyan L. Stiles United States
Guoqiang Jiang China
Arthur J. Sytkowski United States
Florian Überall Austria
Xiaoyan Zhu China
Veli‐Matti Leppänen Finland
Yi Feng United Kingdom
Xuemin Xu relative to Marcela Briššová United States Marcela Briššová's profile →
Citations per field
00.5×1.5×2.0×
Marcela Briššová · 1×
Citations per year

Countries citing papers authored by Xuemin Xu

Since Specialization
Citations

This map shows the geographic impact of Xuemin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuemin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuemin Xu more than expected).

Fields of papers citing papers by Xuemin Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuemin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuemin Xu. The network helps show where Xuemin Xu may publish in the future.

Co-authorship network of co-authors of Xuemin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xuemin Xu. A scholar is included among the top collaborators of Xuemin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuemin Xu. Xuemin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 1
3 2
4 1
5 4
6 4
7 11
8 9
9 3
10 7
11 9
12 10
13 20
14 33
15 32
16 118
17 50
18 37
19 35
20 14

About Xuemin Xu

Xuemin Xu is a scholar working on Molecular Biology, Physiology and Immunology, having authored 92 papers that have together received 2.7k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (19 papers), Mitochondrial Function and Pathology (11 papers) and Protein Kinase Regulation and GTPase Signaling (11 papers). The work is most often cited by research in Physiology (636 citations), Immunology (496 citations) and Molecular Biology (1.6k citations). Xuemin Xu has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Mei‐Zhen Cui, Gary Bokoch, Takao Yagi, Akemi Matsuno‐Yagi, Guozhang Mao, Tsung‐Hsien Chuang, Mingqi Tan, Hao Feng, Jianxin Tan and Yunzhou Dong. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026